What it costs
Prices, coupons, insurance and the arithmetic of paying cash, checked against the seller's own page.
The cheapest GLP-1 we track today is $69/mo at SnagRx, checked October 2026. Every GLP-1 price
What it costsCan you use an HSA or FSA for a GLP-1? What the IRS text saysUsually yes, for the drug. IRS Publication 502 counts "prescribed medicines and drugs" as medical expenses, and HSAs, FSAs and HRAs pay for those expenses tax free. A weight-loss program fee is different: it counts only when the weight loss treats "a specific disease diagnosed by a physician (such as obesity...)". Novo and Lilly both take HSA and FSA cards, many telehealth programs do too, and your plan administrator has the final say on any claim.What it costsEmbody vs Trimi: which compounded GLP-1 program costs less, plan by planAs of October 2026, Embody is cheaper than Trimi on every plan length both publish. On a 12-month plan, compounded semaglutide is $69 a month at Embody ($828 up front) against $99 at Trimi ($1,188 up front), and tirzepatide is $119 ($1,428) against $125 ($1,500). Month to month the gap widens: Embody charges $79 for semaglutide and $129 for tirzepatide. Neither charges a membership fee. Trimi serves all 50 states; Embody excludes Louisiana.What it costsMounjaro cost: the list price, the $25 card, and the $499 self-pay priceLilly puts Mounjaro's list price at $1,112.16 per fill, which is what a pharmacy bills without coverage. With commercial insurance that covers it for type 2 diabetes, the Mounjaro Savings Program brings it to as little as $25 for up to three months. Paying cash, LillyDirect sells every Mounjaro strength self-pay starting at $499 a month. Zepbound, the same tirzepatide in a weight-loss box, starts lower at $299, and compounded tirzepatide lower still.What it costsRo, Hims, Noom, WeightWatchers, Found, Calibrate: what each GLP-1 program actually chargesThe big-name programs price two things separately, the membership and the medication, and the headline you see is usually one of them. Ro charges a $149 monthly membership ($74 a month if you prepay a year) plus $149 to $299 for branded drugs. WeightWatchers Clinic is $74 a month on a 12-month plan, after a $25 first month, plus medication from $149. Calibrate is $199 a month on a three-month commitment, medication separate. Found advertises compounded GLP-1s from $99 a month on its insurance-supported tier and $169 cash on an annual plan, with no fee. Hims and Noom do not publish a price on a page we can read.What it costsZepbound without insurance: every dose priced, and what the vial changesWithout insurance, Zepbound costs $299 a month at the 2.5 mg starting dose and $399 at 5 mg, bought direct from Lilly. From 7.5 mg up the vial and the KwikPen are both $449 a month as long as each refill arrives within 45 days of the last; miss that window and it is $499 at 7.5 mg and $699 from 10 mg. That replaces a list price Lilly itself puts at $499 to $1,086.37 per fill. A year of 13 four-week fills at the trial doses is about $5,800 on refills kept on time and $9,087 at the regular price. Compounded tirzepatide, which is not FDA-approved, starts at $85 a month on our board.What it costsThe Zepbound savings card: two programs, not oneLilly runs two different Zepbound savings programs and which one you get depends on whether your insurance covers Zepbound at all. If it does, the card can bring you to as little as $25 a month, capped at $100 of savings for a one-month fill. If your plan does not cover it, you are on a different program that puts a one-month single-dose pen fill at $499, or a KwikPen fill at $299 to $449 by dose. Separately, Lilly sells the KwikPen and vial direct at $299 to $699 by dose, and government beneficiaries are excluded from the card entirely.What it costsThe Mounjaro savings card, and why its cap beats Zepbound'sLilly's Mounjaro card can bring a covered patient to as little as $25, and its savings cap is $150 a month, which is higher than Zepbound's $100 and higher than Novo's $100 on Ozempic and Wegovy. If your plan does not cover Mounjaro, a separate program puts a one-month fill at as low as $499, with a stated annual maximum saving of $8,411 across up to 13 fills a year. Government beneficiaries are excluded from both.What it costsGLP-1s without insurance: what each route actually costsWithout insurance you have three real routes and they are far apart. Buying direct from the manufacturer is the branded one: Novo publishes $349 a month for the Wegovy pen and from $149 for the tablet, Lilly $299 to $699 for Zepbound by dose. Compounded semaglutide or tirzepatide from a telehealth program is a fraction of that but is not FDA-approved. And the savings cards you will be pointed at mostly require commercial insurance, so if you have none they are not available to you at all.What it costsDoes Medicare cover GLP-1s? Ozempic, Wegovy and Zepbound, route by routeYes, by two different routes. Medicare drug plans (Part D, including Medicare Advantage plans with drug coverage) cover Ozempic and Mounjaro for type 2 diabetes. For weight loss, the Medicare GLP-1 Bridge covers Wegovy (pen or pill), the Zepbound KwikPen and Foundayo for a $50 monthly copay from 1 July 2026 to 31 December 2027, if you meet CMS's BMI criteria. The catch: the Bridge runs outside Part D, so that $50 never counts toward your deductible or out-of-pocket cap.What it costsThe Wegovy coupon: what $25 turns into at the counterNovo's Wegovy savings offer advertises as little as $25 a month, and caps the saving at $100. That cap is what decides your number: a $110 copay becomes $25, a $400 copay becomes $300. Government beneficiaries are excluded, so on Medicare or Medicaid the card is closed to you and the Medicare GLP-1 Bridge is the route instead. Without any insurance the card does not apply either, and Novo's own cash price is $349 a month for the pen or from $149 for the tablet.What it costsDoes Medicaid cover GLP-1s? It depends which state, and on whyFor type 2 diabetes, effectively yes everywhere: state Medicaid programmes must cover FDA-approved drugs for medically accepted indications, so Ozempic and Mounjaro are covered for blood sugar, almost always behind prior authorisation. For obesity it is a patchwork. As of January 2026 only 13 state Medicaid programmes covered GLP-1s for weight under fee-for-service. That is changing: CMS's BALANCE model began rolling out to state Medicaid programmes on 1 May 2026, but joining is voluntary for each state, and Medicaid out-of-pocket costs stay limited to nominal amounts under federal law.What it costsGoodRx for GLP-1s: what the discount actually isGoodRx works best on generics, and every GLP-1 is a brand-name drug with no generic. Its own pages advertise Ozempic from $149 against an average retail price of $1,212.63, and Wegovy from $149 against $1,642.80. That $149 is the manufacturer's own published tablet price rather than a pharmacy discount GoodRx negotiated, so the headline saving and Novo's own offer are the same thing. GoodRx also cannot be combined with insurance or with a manufacturer copay card, though unlike those cards it is open to people on Medicare.What it costsGeneric tirzepatide: there is none, the patent runs to 2036, and here is what costs less todayThere is no generic tirzepatide, generic Zepbound or generic Mounjaro, and FDA's Orange Book shows why: Lilly's patent on the molecule runs to May 13, 2036, with formulation and use patents to 2039 and 2041. Until then the legal routes are Lilly's own self-pay prices, from $299 a month for Zepbound, and compounded tirzepatide, which is not FDA-approved and starts at $85 a month on our board.What it costsTirzepatide cost: every price for the molecule, per month, per mg and per yearTirzepatide costs between $25 and $1,112.16 a month in the United States, depending on the name on the box and who pays. Compounded tirzepatide runs $85 to $399 a month on our board. Zepbound bought direct from Lilly is $299 at 2.5 mg and $399 at 5 mg, then $449 when each refill lands within 45 days. Mounjaro on LillyDirect is $499 at every strength. Covered by commercial insurance, either can drop to $25 with Lilly's card. No generic exists.What it costsTrumpRx GLP-1 prices: what Wegovy, Zepbound, Ozempic and Foundayo cost thereTrumpRx.gov does not sell GLP-1s. It lists each maker's own cash price and passes you to the maker: a Novo coupon you show at the pharmacy, or LillyDirect for Lilly's drugs. On 8 October 2026 it showed the Wegovy pill at $149 to $299 a month by dose, the Wegovy pen and Ozempic at $199 for two new-patient fills then $349, Zepbound at $299 to $449 and Foundayo at $149 to $299. Those match what NovoCare and LillyDirect publish, and they are cash only.What it costsDoes your employer cover GLP-1s for weight loss? The 2026 numbers, who dropped it, and what to doAbout one large employer in five covers GLP-1s for weight loss: 19% of firms with 200 or more workers in KFF's 2025 survey, rising to 43% of firms with 5,000 or more. Among the very largest employers coverage is now falling, from 72% in 2025 to 60% in 2026 in Business Group on Health's survey, and Cigna, PwC, HCA and several state plans have dropped it. Here is who covers it, the usual conditions, and how to check your own plan.What it costsThe Rybelsus coupon now works on the Ozempic pillYour Rybelsus savings offer still works, but on the Ozempic pill: Novo Nordisk says Rybelsus is being replaced by it, and an existing offer carries over without signing up again. The terms are Novo's usual ones, as little as $25 a month with the saving capped at $100. What is new is a cash route: NovoCare Pharmacy sells the Ozempic pill self-pay from $149 a month, and switching needs a new prescription.What it costsWegovy alternatives: every cheaper route, ranked by what it costsThe cheapest alternative to Wegovy is compounded semaglutide: the same active ingredient, made by licensed pharmacies and sold through telehealth programs for a fraction of Novo Nordisk's price, and not FDA-approved. If you want an approved drug, the cheaper routes are Wegovy itself through NovoCare, the Wegovy pill, Lilly's self-pay Zepbound and the Foundayo pill. This guide prices each one from the maker's published terms and today's board.What it costsEmbody vs SnagRx: same advertised price, different plan termsAs of October 2026, SnagRx is the cheaper of the two if you pay month to month: SnagRx advertises compounded semaglutide at $69 and tirzepatide at $119, where Embody charges $79 and $129 one month at a time. On a 12-month plan they tie, because Embody's $69 and $119 are 12-month rates ($828 and $1,428 up front). SnagRx does not name its plan term before the intake quiz, so confirm it at checkout. Neither charges a membership fee and neither serves Louisiana.What it costsHims vs Ro: what each GLP-1 membership costs once the drug is addedAs of October 2026, Hims and Ro cost the same if you pay month to month: both charge a $149 monthly membership after a discounted first month, with the drug billed on top at matching starting prices, such as $149 for the Wegovy pill. Ro is cheaper only on its prepaid membership, $74 a month on a 12-month plan ($888 up front), which brings the starting Wegovy pill to $223 a month all in. We partner with neither, and partner programs on our board start lower.What it costsZepbound alternatives: every cheaper route, ranked by what it costsThe cheapest alternative to Zepbound is compounded tirzepatide: the same active ingredient, made by licensed pharmacies and sold through telehealth programs for a fraction of Lilly's price, and not FDA-approved. If you want an approved drug, the cheaper routes are Lilly's own self-pay Zepbound, Wegovy through NovoCare, and the two weight-loss pills, the Wegovy pill and Foundayo. This guide prices each one from the maker's published terms and today's board.What it costsThe Ozempic coupon: $25 for up to 3 months, and why your copay decides the restWith commercial insurance, Novo's Ozempic savings offer lets you pay as little as $25 a month for up to 3 months, capped at $100 off each month, so it trims a copay rather than setting it. Ozempic is the diabetes drug, so plans cover it more readily than the weight-loss brands and the card often does reach $25. Government beneficiaries are excluded. Paying cash, Novo publishes $349 a month up to 1 mg and $499 at 2 mg.What it costsThe Wegovy pill: what each dose costs, and how it compares with the penWegovy is now sold as a daily tablet as well as a weekly injection, and the tablet self-pays cheaper. Novo's published prices run $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg. The $149 offer on 4 mg ended on 31 August 2026. There are also three different semaglutide pills on the market now, which is the thing most pages about this have not caught up with.What it costsGLP-1 patient assistance programs: what Lilly Cares and Novo's PAP actually coverBoth makers run free-drug programs for people with low income and no insurance or Medicare, but neither covers its weight-loss GLP-1. Novo Nordisk's Patient Assistance Program supplies Ozempic injections free to uninsured patients at or below 200% of the federal poverty level, and lists no Wegovy and no pills. Lilly Cares lists Trulicity as its only GLP-1: no Mounjaro, no Zepbound, no Foundayo. For weight loss, the realistic low-cost routes are the Medicare GLP-1 Bridge at $50 a month and the cash market.What it costsGLP-1 coupons and copay cards: the $25 headline and the $100 capNovo Nordisk advertises paying as little as $25 a month for Wegovy and Ozempic with its savings cards. The same terms attach a maximum saving of $100 a month, and that is the number that decides whether the card helps you. It reduces your copay by up to $100, so a $110 copay becomes $25 and a $400 copay becomes $300. Government beneficiaries, including anyone on Medicare or Medicaid, are excluded. If the card does work for you it beats every cash price we track, which is worth saying on a site that earns commission on the alternatives.
